Nov 18, 2020 / 02:40PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst
Good morning or good afternoon, everyone, depending on where you are in the world. I'm Dave Windley with Jefferies Healthcare Equity Research. I'm so pleased to have you join our Virtual London Healthcare Conference this year.
We are in our second day and progressing through here in this time slot, we're pleased to have Charles River Laboratories here to present to you and have a fireside chat Q&A with me.
And representing Charles River is the company CEO, Jim Foster. And along with him, Todd Spencer, the company's Head of IR. So here to kick off, I'm going to hand it over to Jim to make a few remarks, and then we'll get into some Q&A. So Jim, take it away.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Thanks, Dave. Always nice to be with you, albeit virtually. So we reported our third quarter recently. We had a very strong quarter. Our top line was almost 8%. Non-GAAP operating margin was almost 23%, up
Charles River Laboratories International Inc at Jefferies Virtual London Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot